BACKGROUND: Clinical observations support the hypothesis that stressful events increase relapse occurrence in multiple sclerosis patients, while stress-reduction strategies can modulate this effect. However, a direct cause-effect relationship between stress level and relapse cannot be firmly established from these data. OBJECTIVES: The purpose of this work was to address whether modulation of stress could interfere with symptom relapse in an animal model of multiple sclerosis with relapsing-remitting course. METHODS: Mice bred in standard or enriched environment were subjected to repeated acute stress during the remission phase of relapsing-remitting PLP-induced experimental autoimmune encephalomyelitis. RESULTS: We report that repeated acute stress induced a twofold increase in relapse incidence in experimental autoimmune encephalomyelitis. On the other hand, environmental enrichment reduced relapse incidence and severity, and reversed the effects of repeated acute stress. CONCLUSION: These data provide the platform for further studies on the biological processes that link stress and multiple sclerosis relapses in a suitable animal model.
BACKGROUND: Clinical observations support the hypothesis that stressful events increase relapse occurrence in multiple sclerosis patients, while stress-reduction strategies can modulate this effect. However, a direct cause-effect relationship between stress level and relapse cannot be firmly established from these data. OBJECTIVES: The purpose of this work was to address whether modulation of stress could interfere with symptom relapse in an animal model of multiple sclerosis with relapsing-remitting course. METHODS: Mice bred in standard or enriched environment were subjected to repeated acute stress during the remission phase of relapsing-remitting PLP-induced experimental autoimmune encephalomyelitis. RESULTS: We report that repeated acute stress induced a twofold increase in relapse incidence in experimental autoimmune encephalomyelitis. On the other hand, environmental enrichment reduced relapse incidence and severity, and reversed the effects of repeated acute stress. CONCLUSION: These data provide the platform for further studies on the biological processes that link stress and multiple sclerosis relapses in a suitable animal model.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous
system that leads to various neurological manifestations, including sensitive and
motor symptoms. In the most frequent form, the relapsing-remitting subtype, these
symptoms occur in an unpredictable manner during periods of relapses, followed by
periods of remissions when signs of disease activity are reduced or absent. There is
considerable interest in identifying the factors that lead to the occurrence of
relapse.Clinical observations have suggested a link between acute stress and occurrence of
relapses in MS patients. Considering the lack of prospective studies using objective
measures of stress, there is still no consensus to conclude on the effect of stress
on MS onset and relapses.[1] However, several studies report that acute stressful life events (marital
separation, difficulties at work, changes in place of residence, death of a
relative, etc.)[2] increase the probability for MS patients to experience a relapse.[3] A prospective study showed that three or more stressful life events in a four
week period led to a fivefold increase of MS relapse rate, and that the presence of
at least one stressful life events is sufficient to increase by threefold the rate
of relapse during the following four weeks.[4] Conversely, stress reduction strategies have shown positive effects in MS patients.[5]Considering these clinical observations, several studies have attempted to reproduce
the effects of stress in animal models of MS. In most cases, stress was shown to
reduce, rather than increase, the severity of experimental autoimmune
encephalomyelitis (EAE).[6] However, most of the studies have used chronic stress (more than one hour per
day for more than five days),[6] which has long been known to inhibit immune response, rather than acute
stress events. One study reported an advance in the onset of EAE after repeated
acute stress.[7] More recently, mild chronic stress was shown to exacerbate and accelerate the
clinical symptoms of rat EAE.[8] However, in all of these earlier studies, the stress paradigm was applied in
the early phase, prior to symptom onset, and not during the remission phase. Thus,
these studies did not allow addressing the effect of stress on relapses in
relapsing-remitting context.Overall, the question remains of whether acute stress, when occurring during
remission periods, can influence the incidence and severity of relapses. In
addition, the effect of stress reduction on relapses was never tested in
relapsing-remitting animal models of MS. To answer these questions, we set up a
paradigm of repeated acute stress applied during the remission phase of
relapsing-remitting EAE. We observed that stress exposure precipitated relapse, so
that in stressed animals, the incidence of relapse was doubled, and the delay before
the occurrence of relapse was significantly reduced. Conversely, environmental
enrichment, previously shown to reduce stress in rodents, reduced relapse incidence
and severity, and reversed the effects of stress.
Methods
Animals
Experiments were performed on female SJL/J mice (Janvier, Le Genest-Saint-Isle,
France) maintained under specific pathogen-free conditions at the Centre
Universitaire de Ressources Biologiques (Basse-Normandie, France). This study
and the procedures thereof were approved by the French ministry of education and
research (Project licence APAFIS#2887-2015112017418114v2; Center agreement
#D14118001) in accordance with the French (Decree 87/848) and European
(Directive 86/609) guidelines. Animals were monitored once a day for signs of
pain, posture, reactivity, activity, signs of distress, food/drink consumption
and follow-up of body weight. Humane euthanasia was planned to be applied to any
animal showing at least one of the following signs: prostration, body weight
loss > 20%, lack of reaction, prolonged inactivity or other signs of
distress, stop of food and/or drink consumption.
Experimental autoimmune encephalomyelitis (EAE)
Relapsing remitting EAE (PLP-induced EAE) was
induced in 8-week-old female SJL/J mice via subcutaneous immunization with
200 µg recombinant myelin proteolipid protein (PLP139–151,
Eurogentec) in an emulsion mix (volume ratio 1:1) with Complete Freund's
Adjuvant (CFA; Difco Laboratories) containing 800 µg of heat-killed
Mycobacterium tuberculosis H37Ra (MBT; Difco). The emulsion was administered to
regions above the shoulders and the flanks (total of 4 sites; 50 μl at each
injection site). All animals were injected intraperitoneally with 200 ng
pertussis toxin derived from Bordetella pertussis (Sigma-Aldrich) in 200 µL
saline at the time of, and after 48 hours following immunization. EAE induction
was performed with the application of local analgesia (lidocaine patch) to
prevent discomfort and pain. The animals were euthanized 80 days after EAE
induction under deep anesthesia (5% isoflurane, O2/N2O 1/1) by exsanguination
via intracardiac infusion of saline.
Clinical score
Mice were examined daily for clinical signs of EAE and were scored as followed:
0, no disease; 1, limp tail; 2, hindlimb weakness; 3, complete hindlimb
paralysis; 4, hindlimb paralysis plus forelimb paralysis; and 5, moribund or
dead. All clinical score were assessed daily by an examiner blinded to the EAE
group. A relapse was defined as a sustained increase (minimum duration of 2
days) of at least 0.5 in clinical score.
Water avoidance stress (WAS)
WAS (one hour per day during four days) was performed by placing asymptomatic EAE
mice on a platform (4cm diameter) positioned at the center of a plastic
container filled with water at room temperature up to 1 cm below the top of the
platform. EAE mice were randomly assigned to the two experimental groups.
Non-WAS mice were handled identically, but placed in an empty and clean
cage.
Standard breeding conditions
Mice in standard (STD) conditions were placed in standard cages [32 × 16 × 14 cm
(L × W × H)], which allowed social interactions (5 mice per cage). Nesting
material was placed in the cage and renewed if needed. The animals had
ad libitum access to food and water.
Environmental enrichment (EE)
Enriched mice were housed in Marlau™ cages [Viewpoint; 58 × 40 × 32 cm
(L × W × H)], which allowed social interactions (15 mice per cage). These cages
are composed of two floors. The ground floor has two compartments: one
containing food, the other one containing water bottles, three running wheels
and an elevated nest. The upper floor contains a maze changed three times a
week. Because of one-way doors between the two ground compartments, mice had to
climb to the upper floor using a ladder, pass through the maze and go down to
the food compartment using a slide tunnel to reach food. Enriched mice were
housed in these Marlau™ cages from the age of six weeks to the end of the
experiment. Enrichment was thus applied before EAE induction and during all the
phases of EAE, including presymptomatic phase, first peak, remission and
relapses. There are no documented differences on stress scores, stress
measurements or stress biomarkers across the two particular breeding conditions
used in the present work. Nevertheless, environmental enrichment has been
described before to reduce stress in laboratory rodents.[9]
Statistical analysis
Results are presented as the mean ± SEM. Normality tests were performed on all
samples (D'Agostino-Pearson omnibus test and Shapiro-Wilk test). When normality
could not be assumed, we used non-parametric tests (Mann-Whitney's U-test),
which are the most stringent in these conditions. For the comparison of the mean
clinical scores, we used a two-way repeated measures ANOVA followed by a
Bonferroni’s multiple comparison post hoc test. For the
comparison of the number of feces in STD, STD+WAS, EE and EE+WAS groups, we used
a Kruskall-Wallis test followed by a Dunn’s multiple comparison as a
post hoc test. Onset and relapse incidence curves were
analysed with Gehan-Breslow-Wilcoxon test. Data were analysed using GraphPad
Prism 7.0. Two groups were considered to be significantly different when
P< 0.05.
Results
Repeated acute stress has been defined as a short exposure to stressing stimulus
(<1h) repeated once daily during less than 5 days (as opposed to repeated chronic
stress: >1h during more than 5 days).[6] Here, to induce repeated acute stress, we applied a paradigm in which mice
were exposed to water avoidance stress (WAS) once a day during 4 days during the
remission period of EAE (Figure
1(a) and (b)). The stressful nature of this paradigm was assessed by
measuring fecal pellet output during the exposure to stress (Figure 1(c)), as a measure of stress-induced
colonic motility.[10] This procedure is fully non-invasive and was preferred to other methods such
as measurement of stress hormones in the blood-stream that require invasive
procedures and thus constitute a source of stress for the animals.
Figure 1.
Experimental design for water avoidance stress. (a) Water avoidance stress
(WAS, one hour per day for four days) was applied during the remission phase
of PLP-induced relapsing-remitting EAE mice and the clinical scoring was
assessed during 60 days. (b) Photography of the experimental system. Mice
were placed for 1 hour on a platform positioned at the center of a plastic
container filled with water at room temperature up to 1 cm below the
platform level. Mice were randomly assigned to the two experimental groups.
Non-WAS mice were handled identically, but placed in a standard cage. (c)
Measure of fecal pellet outputs in the two experimental groups as an index
of stress-induced colonic motility (n = 26 and n = 28 for EAE and EAE+WAS
groups respectively). ***P<0.001;
****P<0.0001, Mann Whitney’s U-test.
Experimental design for water avoidance stress. (a) Water avoidance stress
(WAS, one hour per day for four days) was applied during the remission phase
of PLP-induced relapsing-remitting EAE mice and the clinical scoring was
assessed during 60 days. (b) Photography of the experimental system. Mice
were placed for 1 hour on a platform positioned at the center of a plastic
container filled with water at room temperature up to 1 cm below the
platform level. Mice were randomly assigned to the two experimental groups.
Non-WAS mice were handled identically, but placed in a standard cage. (c)
Measure of fecal pellet outputs in the two experimental groups as an index
of stress-induced colonic motility (n = 26 and n = 28 for EAE and EAE+WAS
groups respectively). ***P<0.001;
****P<0.0001, Mann Whitney’s U-test.The exposure to stress induced an increase in clinical score which reached
significance at days 42, 43, 44, and 58 (Figure 2(a)). These differences in mean
clinical score were explained by the fact that WAS advanced the appearance of the
relapse (mean day of relapse onset: 40.53 ± 3.43 vs. 55.33 ± 4.92;
P = 0.0189; mean duration of remission: 23.67 ± 3.66 vs.
38.0 ± 4.91; P = 0.0273; Table 1), so that the incidence of relapse
was increased by 1.58-fold at day 75 (Figure 2(b); Supplementary Figure 1A).
Noteworthy, the severity of EAE was not affected by stress (mean peak score:
2.77 ± 0.29 vs. 2.50 ± 0.47. Table 1).
Figure 2.
Acute stress precipitates relapse in EAE animals. (a) Clinical score was
assessed daily by an examiner blinded to the treatment (n = 26 and n = 28
for EAE and EAE+WAS groups respectively; *P<0.05,
two-way repeated measures ANOVA + Bonferroni’s multiple comparison). (b)
Clinical evaluation expressed as the long-term relapse incidence in EAE and
EAE+WAS groups (*P<0.05, Gehan-Breslow-Wilcoxon
test).
Table 1.
Values for mean day of onset or relapses and mean peak clinical score in the
EAE and EAE+WAS groups.
EAE
N
EAE + WAS
N
P-value
Mean day of onset
11.50 ± 0.15
30/35
11.57 ± 0.21
30/35
0.7510
Peak score
2.52 ± 0.19
2.52 ± 0.19
0.7036
Mean duration of remission
38.00 ± 4.91
23.67 ± 3.66
0.0273*
Mean day of first relapse onset
55.33 ± 4.92
9/26
40.53 ± 3.43
15/28
0.0189*
Peak score
1.72 ± 0.41
2.20 ± 1.40
0.4066
Mean day of second relapse onset
62.80 ± 6.00
5/26
52.40 ± 4.36
10/28
0.1885
Peak score
3.00 ± 0.55
2.05 ± 0.28
0.1092
Mean day of third relapse onset
66.00 ± 0
1/26
63.50 ± 2.92
6/28
N.D.
Peak score
4 ± 0
2.42 ± 0.42
N.D.
Peak score (all relapse)
2.50 ± 0.47
9/26
2.77 ± 0.29
15/28
0.6130
N corresponds to the number of animals with first surge or relapse
divided by the total number of animals within the group (see
Supplementary Figure 1A for a detailed description). The data are given
for the animals that develop a first peak. P values are
given for t-test or, when normality could not be assumed, Mann-Whitney’s
U-test. *p < 0.05.
Acute stress precipitates relapse in EAE animals. (a) Clinical score was
assessed daily by an examiner blinded to the treatment (n = 26 and n = 28
for EAE and EAE+WAS groups respectively; *P<0.05,
two-way repeated measures ANOVA + Bonferroni’s multiple comparison). (b)
Clinical evaluation expressed as the long-term relapse incidence in EAE and
EAE+WAS groups (*P<0.05, Gehan-Breslow-Wilcoxon
test).Values for mean day of onset or relapses and mean peak clinical score in the
EAE and EAE+WAS groups.N corresponds to the number of animals with first surge or relapse
divided by the total number of animals within the group (see
Supplementary Figure 1A for a detailed description). The data are given
for the animals that develop a first peak. P values are
given for t-test or, when normality could not be assumed, Mann-Whitney’s
U-test. *p < 0.05.Environmental enrichment has been described as an efficient paradigm to reduce stress
in laboratory rodents.[9] Here, we bred mice in standard or enriched environment prior to EAE induction
and exposure to repeated acute stress (Figure 3(a) and (b)). This paradigm of
standard enrichment reversed the increase of fecal pellet output (used as index of
stress-induced colonic motility) induced by WAS (Figure 3(c)).
Figure 3.
Experimental design for environment enrichment. (a) Environmental enrichment
(EE) was applied from 14 days pre-EAE induction to the end of the protocol.
Standard (STD) animals were kept in standard breeding conditions. WAS was
applied to half of the animals of each group during the remission phase of
EAE. In total, 4 experimental groups were studied: STD, STD+WAS, EE, EE+WAS.
(b) Photography of the STD and EE breeding cages (see methods for details).
(c) Measure of fecal pellet outputs in the four experimental groups as an
index of stress-induced colonic motility (n = 16, n = 21, n = 12 and, n = 12
for STD, STD+WAS, EE, and EE+WAS groups respectively;
*P<0.05; ***P<0.001, STD vs.
STD+WAS; P<0.0001, EE vs. STD+WAS;
†††P<0.001, EE+WAS vs. STD+WAS;
Kruskall-Wallis test + Dunn’s multiple comparison).
Experimental design for environment enrichment. (a) Environmental enrichment
(EE) was applied from 14 days pre-EAE induction to the end of the protocol.
Standard (STD) animals were kept in standard breeding conditions. WAS was
applied to half of the animals of each group during the remission phase of
EAE. In total, 4 experimental groups were studied: STD, STD+WAS, EE, EE+WAS.
(b) Photography of the STD and EE breeding cages (see methods for details).
(c) Measure of fecal pellet outputs in the four experimental groups as an
index of stress-induced colonic motility (n = 16, n = 21, n = 12 and, n = 12
for STD, STD+WAS, EE, and EE+WAS groups respectively;
*P<0.05; ***P<0.001, STD vs.
STD+WAS; P<0.0001, EE vs. STD+WAS;
†††P<0.001, EE+WAS vs. STD+WAS;
Kruskall-Wallis test + Dunn’s multiple comparison).Strikingly, animals bred in enriched environment showed a reduction in the first
symptomatic peak of EAE (Days 12-17 post immunization, Figure 4(a)) and a drastic reduction of
clinical score during the relapse phase (days 48-71 and 73-78, Figure 4(a)). These differences in mean
clinical score along the course of EAE were the result of several parameters: First,
the incidence of the disease and the incidence of relapse were reduced in enriched
animals (Figure 4(b) and
(c)), so that the incidence of disease was decreased by 1.52-fold at day 25
(Figure 4(b),
Supplementary Figure 1B) and the incidence of relapse was decreased by 2.06-fold at
day 70 (Figure 4(c),
Supplementary Figure 1C). Second, the onset of the disease tended to occur later in
enriched animals (mean day of relapse onset: 14.67 ± 0.41 vs. 13.74 ± 0.35 vs.;
P = 0.0581; Table 2).
Figure 4.
Environmental enrichment reduced EAE severity. (a) Clinical score assessed
daily by an examiner blinded to the treatment in the standard (STD) and
enriched environment (EE) groups (n = 53 and n = 51 for STD and EE groups
respectively; *P<0.05; **P<0.01,
two-way repeated measures ANOVA + Bonferroni’s multiple comparison). (b)
Clinical evaluation expressed as the EAE onset incidence in EE and STD
groups (**P<0.01, Gehan-Breslow-Wilcoxon test). (c)
Clinical evaluation expressed as the long-term EAE relapse incidence in EE
and STD groups (n = 16 and n = 12 for STD and EE groups respectively;
P = 0.0922, Gehan-Breslow-Wilcoxon test).
Table 2.
Values for mean day of onset, mean day of relapse and mean peak clinical
score in the STD or EE groups.
STD EE
N
P-value
N
Mean day of onset
13.74 ± 0.35
38/53
14.67 ± 0.41
24/51
0.0581
Peak score
1.64 ± 0.17
1.27 ± 0.16
0.2070
Mean day of first relapse onset
44.18 ± 3.33
11/16
46.75 ± 10.63
4/12
0.7597
Peak score
1.64 ± 0.44
1.63 ± 0.47
0.5963
Mean day of second relapse onset
55.29 ± 4.11
7/16
47.00 ± 0
1/12
N.D.
Peak score
2.43 ± 0.46
1.50 ± 0
N.D.
Mean day of third relapse onset
65.00 ± 2.42
4/16
69.00 ± 0
1/12
N.D.
Peak score
2.63 ± 0.55
1.50 ± 0
N.D.
Peak score (all relapse)
2.77 ± 0.37
11/16
1.63 ± 0.47
4/12
0.1143
N corresponds to the number of animals with first surge or relapse
divided by the total number of animals within the group (see
Supplementary Figure 1B for a detailed description). The data are given
for the animals that develop a first peak. P values are
given for t-test or, when normality could not be assumed, Mann-Whitney’s
U-test.
Environmental enrichment reduced EAE severity. (a) Clinical score assessed
daily by an examiner blinded to the treatment in the standard (STD) and
enriched environment (EE) groups (n = 53 and n = 51 for STD and EE groups
respectively; *P<0.05; **P<0.01,
two-way repeated measures ANOVA + Bonferroni’s multiple comparison). (b)
Clinical evaluation expressed as the EAE onset incidence in EE and STD
groups (**P<0.01, Gehan-Breslow-Wilcoxon test). (c)
Clinical evaluation expressed as the long-term EAE relapse incidence in EE
and STD groups (n = 16 and n = 12 for STD and EE groups respectively;
P = 0.0922, Gehan-Breslow-Wilcoxon test).Values for mean day of onset, mean day of relapse and mean peak clinical
score in the STD or EE groups.N corresponds to the number of animals with first surge or relapse
divided by the total number of animals within the group (see
Supplementary Figure 1B for a detailed description). The data are given
for the animals that develop a first peak. P values are
given for t-test or, when normality could not be assumed, Mann-Whitney’s
U-test.Considering that repeated acute stress increased relapse rate and that environmental
enrichment reduced the severity of EAE, our next question was to ask as to whether
environmental enrichment may reduce the effects of stress. Mice bred in standard or
enriched environment were subjected to WAS during the remission period (Figure 3(a)). In agreement
with above results, mice bred in enriched environment showed a reduction in clinical
score during the first peak of disease (days 13–14 and 16–17, Figure 5(a)). The mean clinical score
gradually increased after the remission period in standard animals, but not in
enriched animals (Figure
5(a)), reaching statistical difference at day 41, between days 43 and 50
and from day 52 to the end of the experiment (day 78). This difference was the
reflect of a dramatic difference in the incidence of relapse (71.4% vs. 8.3%,
P = 0.0011; Figure 5(b), Supplementary Figure 1B). Only one animal (from n = 12)
suffered a relapse in the enriched group (Supplementary Figure 1B), and that relapse
occurred much later than what observed in the standard group (61 days vs. a mean of
43.73 ± 3.15 in standard animals; Table 3). The peak score of this relapse
was also reduced as compared to the mean of the standard group (1.5 ± 0 vs.
2.00 ± 0.32; Table 3).
In addition, although 60% of the animals with a first relapse (9 animals out of 15)
also suffered a second relapse later in the standard group (58.43 ± 4.28 days post
immunization; Table 3),
no second relapse was observed in the enriched group.
Figure 5.
Environmental enrichment reversed the effects of stress on EAE severity. (a)
Clinical score assessed daily by an examiner blinded to the treatment in the
STD+WAS and EE+WAS groups (n = 21 and n = 12 for STD+WAS and EE+WAS groups
respectively; *P<0.05; **P<0.01;
***P<0.001, two-way repeated measures
ANOVA +Bonferroni’s multiple comparison). (b) Clinical evaluation expressed
as the long-term EAE relapse incidence in STD+WAS and EE+WAS groups (n = 21
and n = 12 for STD+WAS and EE+WAS groups respectively; **P<0.01,
Gehan-Breslow-Wilcoxon test).
Table 3.
Values for mean day of relapse onset and mean peak clinical score in the
STD+WAS and EE+WAS groups.
STD+WAS EE+WAS
P-value
N
N
Mean day of first relapse onset
43.73 ± 3.15
15/21
61.00 ± 0
1/12
N.D.
Peak score
2.00 ± 0.32
1.50 ± 0
N.D.
Mean day of second relapse onset
58.43 ± 4.28
9/21
N.D.
0/12
N.D.
Peak score
2.36 ± 0.31
N.D.
N.D.
Mean day of third relapse onset
56.00 ± 2.00
2/21
N.D.
0/12
N.D.
Peak score
2.50 ± 1.00
N.D.
N.D.
Mean day of fourth relapse onset
76.00 ± 0
1/21
N.D.
0/12
N.D.
Peak score
1.00 ± 0
N.D.
N.D.
Peak score (all relapse)
2.50 ± 0.30
15/21
1.50 ± 0
1/12
N.D.
N corresponds to the number of animals with first surge or relapse
divided by the total number of animals within the group (see
Supplementary Figure 1B for a detailed description). The data are given
for the animals that develop a first peak.
Environmental enrichment reversed the effects of stress on EAE severity. (a)
Clinical score assessed daily by an examiner blinded to the treatment in the
STD+WAS and EE+WAS groups (n = 21 and n = 12 for STD+WAS and EE+WAS groups
respectively; *P<0.05; **P<0.01;
***P<0.001, two-way repeated measures
ANOVA +Bonferroni’s multiple comparison). (b) Clinical evaluation expressed
as the long-term EAE relapse incidence in STD+WAS and EE+WAS groups (n = 21
and n = 12 for STD+WAS and EE+WAS groups respectively; **P<0.01,
Gehan-Breslow-Wilcoxon test).Values for mean day of relapse onset and mean peak clinical score in the
STD+WAS and EE+WAS groups.N corresponds to the number of animals with first surge or relapse
divided by the total number of animals within the group (see
Supplementary Figure 1B for a detailed description). The data are given
for the animals that develop a first peak.
Discussion
The present study overall shows that repeated acute stress precipitates relapses in
RR-EAE and that environmental enrichment, previously reported to reduce stress in
laboratory rodents,[9] prevents the occurrence of relapses and alleviates the effect of repeated
acute stress on RR-EAE severity.Controversial results have been reported in the past concerning the effects of stress
on EAE.[11] A general consensus has emerged to state that chronic stress ameliorates,
while acute stress worsens, disease course. The outcome of these studies was
generally the evolution of clinical score in a chronic, monophasic model, rather
than the effect on relapses in a relapsing-remitting model, as described here. The
data presented here show that repeated acute stress during the remission phase of
RR-EAE is sufficient to precipitate relapses in absence of other inducers. These
data complement previous reports of an exacerbation of disease by chronic mild stress.[8] Our data match clinical observation in MS patients, previously summarized in
a meta-analysis[12] and describing that stressful life events exacerbate MS. The paradigm
developed in the present study may therefore be used to investigate the mechanisms
responsible for stress-induced occurrence of relapses. In complement, other
paradigms of repeated acute stress, such as restraint stress or exposure to predator
odors may be used in future studies.The two major stress response systems, the hypothalamic-adrenal-pituitary axis and
the sympathetic nervous system, have been suggested to mediate the effects of stress
on relapses.[13] In addition to these pathways, stress also increases intestinal barrier permeability.[14] Animal studies give a possible link between gut inflammation and MS:
intestinal barrier dysfunction occurs at the onset of monophasic EAE[15] and a pro-inflammatory response in the gut has been shown to trigger
EAE.[16,17] Conversely,
the sequestration of Th17 cells in the gut confers resistance to EAE.[18] Together, these studies suggest a sequence of events involving the gut in the
pathogenesis of EAE: (i) initial expansion and activation of T-cell in
gut-associated lymphoid tissues, leading to (ii) recruitment of
auto-antibody-producing B cells and (iii) migration to brain draining cervical nodes
to finally trigger autoimmune encephalomyelitis. Increased permeability of the
intestinal barrier is a key feature of gut inflammation[19] and could thus initiate this cascade of events, which may potentiated by
stress. In addition, stress may also induce neurovascular pathology, leading to BBB
permeation[20,21] which could provide an additional explanation for the effect of
stress in EAE. The paradigm described in the present work could be useful to test
these mechanistic hypotheses in further studies.While the effects of stress on RR-EAE disease described here corroborate previous
reports in experimental models[8] and coincide with clinical data,[12] more intriguing and novel are our data concerning the effects of
environmental enrichment. Indeed, we show that animals bred in enriched environment
show a reduced severity and incidence of the first RR-EAE peak, and a drastic
amelioration of the second phase of the disease. In addition, environmental
enrichment alleviated the effects of repeated acute stress, applied during the
remission phase, on the incidence of relapse. These data suggest that animals bred
in an enriched environment have lost their sensitivity to repeated acute stress on
RR-EAE symptoms. The fact that environmental enrichment reduces the severity of
RR-EAE from the first peak suggests that this breeding regimen exert a
“conditioning” effect on animals towards a lesser sensitivity to EAE. Interestingly,
although repeated acute stress prompts standard animals towards a higher rate of
relapse, this stress paradigm does not compensate for the beneficial “conditioning”
effect brought by environmental enrichment. Future experiments in which enrichment
would be applied only during remission is a very exciting perspective that would
test the possibility of a therapeutic effect of enrichment in EAE.The mechanism by which environmental enrichment alleviates the effects of stress is
also an intriguing question. Previous report suggested that environmental enrichment
increases cerebral activity in the prefrontal cortex and that this increased
activity participates in setting up stress resiliency.[22] This suggests that environmental enrichment could drive a manner of cerebral
training in rodents that would lead to the reported beneficial effects. However, one
cannot exclude that this regimen may reverse the effects of stress by other-though
not necessarily exclusive- ways. Several positive effects of environmental
enrichment, in addition to cerebral training, may account for its beneficial
effects, including increase in physical activity, or changes in metabolic parameters.[23]In conclusion, this study shows that repeated acute stress increases relapse rate and
incidence in an experimental paradigm relevant to relapsing-remitting MS, the most
frequent form of this disease. These data in animal models have to be seen in the
light of recent successful attempts to use stress management strategies as an
adjunct to the available MS treatments.[24,25] The use of preclinical animal
models may provide rationales and mechanistic explanations for the use of these
strategies in MS management.
Availability of Data and Materials
The datasets used and analysed during the current study are available from the
corresponding author.
Conflict of Interests
The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.Click here for additional data file.Supplemental material, sj-pdf-1-mso-10.1177_2055217320959806 for Environmental
enrichment alleviates the deleterious effects of stress in experimental
autoimmune encephalomyelitis by Antoine Philippe Fournier, Erwan Baudron,
Isabelle Wagnon, Philippe Aubert, Denis Vivien, Michel Neunlist, Isabelle Bardou
and Fabian Docagne in Multiple Sclerosis Journal – Experimental, Translational
and Clinical
Authors: Yun Kyung Lee; Juscilene S Menezes; Yoshinori Umesaki; Sarkis K Mazmanian Journal: Proc Natl Acad Sci U S A Date: 2010-07-26 Impact factor: 11.205